Zobrazeno 1 - 10
of 40
pro vyhledávání: '"MARILYN CAMPION"'
Autor:
Jonathan A. Bernstein, H. Henry Li, Andrew J. MacGinnitie, D. Soteres, Timothy J. Craig, Ryan Iarrobino, Marc A. Riedl, William E. Pullman, William R. Lumry, Leslie E. Stolz, Marilyn Campion
Publikováno v:
Allergy and Asthma Proceedings. 34:155-161
Hereditary angioedema (HAE) is a rare disorder characterized by recurrent attacks of potentially life-threatening edema. The plasma kallikrein inhibitor ecallantide is approved for treatment of acute HAE attacks. This study evaluates the efficacy and
Autor:
Marilyn Campion, Timothy J. Craig, Jonathan A. Bernstein, Andrew J. MacGinnitie, Marc A. Riedl, H. Henry Li, William R. Lumry, Elizabeth P. Shea, D. Soteres
Publikováno v:
Annals of Allergy, Asthma & Immunology. 110:168-172
Background Effective treatment of acute attacks is critical in managing hereditary angioedema (HAE). Ecallantide, a plasma kallikrein inhibitor, is approved for the treatment of HAE attacks. Occasionally, a second dose is needed when treating attacks
Publikováno v:
Allergy and Asthma Proceedings. 33:178-185
Hereditary angioedema (HAE) is characterized by episodic attacks of edema. HAE is caused by low levels of the protein C1 esterase inhibitor, which inhibits plasma kallikrein, the enzyme responsible for converting high-molecular-weight kininogen to br
Autor:
Drucy, Borowitz, Christopher, Stevens, Lee R, Brettman, Marilyn, Campion, Michael, Wilschanski, Henry, Thompson, Robert, Zanni
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 54:248-257
Patients with cystic fibrosis (CF) who have exocrine pancreatic insufficiency (EPI) require treatment with pancreatic enzyme replacement therapy (PERT) to maintain adequate nutrition and age-appropriate growth and weight gain. Liprotamase, a nonporci
Autor:
Drucy, Borowitz, Christopher, Stevens, Lee R, Brettman, Marilyn, Campion, Barbara, Chatfield, Marco, Cipolli, Michael, Wall
Publikováno v:
Journal of Cystic Fibrosis. 10:443-452
BackgroundMost cystic fibrosis (CF) patients have exocrine pancreatic insufficiency (EPI) and need supplementation with pancreatic enzyme replacement therapy (PERT). Liprotamase, a novel non-porcine PERT containing highly purified biotechnology-deriv
Autor:
Ralph Corey, Tahaniyat Lalani, Vance G. Fowler, Bruno Hoen, Zeina A. Kanafani, José M. Miró, Donald P. Levine, Gloria Vigliani, Marilyn Campion, Helen W. Boucher, Christopher H. Cabell
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 28:498-503
Introduction: In a recent randomized trial of Staphylococcus aureus bacteremia and native valve endocarditis, daptomycin was found not inferior to standard therapy. We summarized findings in the subgroup of patients with endocarditis according to the
Autor:
Marco Cicardi, William E. Pullman, Marilyn Campion, Donald L. McNeil, Patrick T. Horn, Robyn J. Levy, H. Henry Li, Albert L. Sheffer
Publikováno v:
New England Journal of Medicine. 363:523-531
Background Hereditary angioedema is a rare genetic disorder characterized by acute, intermittent, and potentially life-threatening attacks of edema of the skin and mucosa. We evaluated ecallantide, a newly developed recombinant plasma kallikrein inhi
Autor:
Elias Abrutyn, Vance G. Fowler, Marilyn Campion, Adolf W. Karchmer, Mark E. Rupp, G. Ralph Corey, Donald P. Levine, Gloria Vigliani, Helen W. Boucher, Henry F. Chambers, Sara E. Cosgrove
Publikováno v:
Clinical Infectious Diseases. 48:713-721
Background. The safety of adding initial low-dose gentamicin to antistaphylococcal penicillins or vancomycin for treatment of suspected Staphylococcus aureus native valve endocarditis is unknown. This study evaluated the association between this prac
Publikováno v:
Journal of Antimicrobial Chemotherapy
OBJECTIVES Administering outpatient parenteral antimicrobial therapy in the community setting (CoPAT) is becoming more common with the increasing emphasis on controlling costs. However, few controlled trials have evaluated this treatment modality. ME
Autor:
G. Ralph Corey, Barry I. Eisenstein, Donald P. Levine, Susan J. Rehm, Helen W. Boucher, Gloria Vigliani, Elias Abrutyn, Marilyn Campion
Publikováno v:
Journal of Antimicrobial Chemotherapy
Objectives In a prospective, randomized trial, daptomycin was non-inferior to standard therapy for Staphylococcus aureus bacteraemia and right-sided endocarditis. Since rates of infection due to methicillin-resistant S. aureus (MRSA) infection are in